本頁面由Tiger Trade Technology Pte. Ltd.提供服務

PTC Therapeutics Inc.

68.69
-2.1600-3.05%
盤後68.690.00000.00%16:44 EDT
成交量:58.76萬
成交額:4,047.34萬
市值:56.86億
市盈率:8.83
高:71.57
開:71.57
低:68.22
收:70.85
52周最高:87.50
52周最低:35.95
股本:8,277.47萬
流通股本:7,297.94萬
量比:0.76
換手率:0.81%
股息:- -
股息率:- -
每股收益(TTM):7.78
每股收益(LYR):7.78
淨資產收益率:-7740.12%
總資產收益率:23.26%
市淨率:-27.69
市盈率(LYR):8.83

資料載入中...

2024/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/07/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/28

重要事件披露

Form 8-K - Current report
2024/06/20

重要事件披露

Form 8-K - Current report
2024/05/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/20

重要事件披露

Form 8-K - Current report
2024/05/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/25

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/25

重要事件披露

Form 8-K - Current report
2024/04/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/29

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]